Premium
Balloon tamponade during cesarean section is useful for severe post‐partum hemorrhage due to placenta previa
Author(s) -
Ishii Takako,
Sawada Kenjiro,
Koyama Shunsuke,
Isobe Aki,
Wakabayashi Atsuko,
Takiuchi Tsuyoshi,
Kanagawa Takeshi,
Tomimatsu Takuji,
Ogita Kazuhide,
Kimura Tadashi
Publication year - 2012
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.2011.01625.x
Subject(s) - medicine , placenta previa , post partum , obstetrics , tamponade , balloon , section (typography) , pregnancy , placenta , surgery , fetus , genetics , biology , advertising , business
Aim: Severe post‐partum hemorrhage during cesarean section due to placenta previa is still one of the leading causes of maternal mortality. The aim of this study was to evaluate the efficiency of intrauterine tamponade with a Sengstaken‐Blakemore tube (SB‐tube) for the treatment of severe post‐partum hemorrhage in cases of placenta previa. Material and Methods: Data were collected from our departmental clinical records on all patients who underwent caesarian section due to placenta previa between 2007 and 2009. Results: During the period analyzed, 37 patients underwent caesarian section due to placenta previa/low‐lying placenta. Four (11%) underwent hysterectomy due to placenta accreta and 33 (89%) were treated conservatively. Of the 33 patients with conserved uterus, 10 (28%) patients required a SB‐tube during the cesarean section because of continuous post‐partum hemorrhage despite appropriate medical treatment. The median bleeding during the operation was 2030 ± 860 mL in the patients who used SB‐tube. None of them presented severe complications related to these procedures or required any further invasive surgery. Conclusion: Intrauterine balloon‐tamponade could successfully control severe hemorrhage from a lower uterine segment of a patient with placenta previa. This technique is simple to use, scarcely invasive, and available at a low cost to all maternity wards, and should be considered as one of the first management options to reduce the risk of undesirable hysterectomy.